Wockhardt Sep qtr net loss at Rs 54.20 cr

Agencies
Posted: Saturday, Oct 31, 2009 at 1755 hrs IST
Updated: Saturday, Oct 31, 2009 at 1755 hrs IST

Font Size

Feedback

Discuss

Ranbaxy recalls drugs for skin disease from US Zenotech Labs June Q net loss widens to Rs 3.41 cr Glenmark settles patent dispute with Medicis

: Pharmaceutical firm Wockhardt reported a consolidated net loss of Rs 54.20 crore for the quarter ended September 30, while it had a net profit of Rs 62.19 crore in the same period last year.

Net sales declined to Rs 922.69 crore in the July- September quarter, against Rs 923.48 crore in the same period previous fiscal, Wockhardt said in a filing to the NSE.

On the standalone basis, the company has posted a net loss of Rs 59.09 crore in September quarter, while it had a net profit of Rs 13.43 crore in the same period previous year.

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.